bitolterol mesylate , 1.0 mg , or isoproterenol hydrochloride , 1.5 mg , was administered three times daily for 3 months in a double-blind , multicenter study via closed-port , intermittent-flow , compressor-driven nebulizer system ( cpif ) to 182 nonsteroid-using patients with asthma .
C0106575
bitolterol mesylate
C0004096
asthma